Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
China Regenerative Medicine International Ltd
of Hong Kong
sales of 27.75 million Hong Kong Dollars [US$3.58 million]
of which 73%
was Cosmetic and Health Products),
(2.47 billion Japanese Yen [US$23.82 million]
of which 64%
was Health Inspection Equipment), and
Ina Research Incorporation
based in Japan
(2.12 billion Japanese Yen [US$20.39 million]
of which 80%
was Non-clinical business).
During the year ended March of 2016, sales at
Hester Pharmaceuticals Limited were 1.01 billion Indian Rupees (US$15.12 million).
increase of 11.3%
versus 2015, when the company's sales were 906.35 million Indian Rupees.
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2011, sales have increased a total of 141%).
Sales of Large Animal Health Production saw an increase
that was more than double the company's growth rate: sales were up
73.2% in 2016, from
54.23 million Indian Rupees to 93.94 million Indian Rupees.